Microcrystalline Titanium Dioxide With Covalently Linked Monovalent Silver Ions
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Microcrystalline Titanium Dioxide With Covalently Linked Monovalent Silver Ions, covering 2018-12-31 to 2019-01-02. Get the full timeline:
Most recent: Clinical Trial Update: Effects of Microcrystalline Titanium Dioxide With Covalently Linked Monovalent Silver Ions on Complications After Total Hysterectomy ( ISTIAB-0) [Phase 3]